Clinical trials
University of California, San Francisco is sponsoring a study to determine the safety and tolerability of TPI 287. They are currently seeking applicants. For more info:
Safety Study of TPI-287 to Treat CBS and PSP (TPI-287-4RT)
cbgd6278
0